key: cord-0919679-yc36uwkv
authors: Deutsch-Link, Sasha; Jiang, Yue; Peery, Anne F.; Barritt, Alfred S.; Bataller, Ramon; Moon, Andrew M.
title: Alcohol-Associated Liver Disease Mortality Increased from 2017-2020 and Accelerated during the COVID-19 Pandemic
date: 2022-03-19
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2022.03.017
sha: 56ef28cc6e6cb4abd37452a4fbf4a86d97ef1af8
doc_id: 919679
cord_uid: yc36uwkv

nan

Age-adjusted ALD-related mortality rates per 100,000 increased each year from 2017 through 2020 for both sexes. Rates rose from 13.1 (95% CI 12.9 -13.3) in 2017 to 16.9 (95% CI 16.7 -17.1) in 2020 among males and from 5.6 (95% CI 5.4 -5.7) in 2017 to 7.7 (95% CI 7.6 -7.9) in 2020 among females. The highest age-adjusted rates were found among American-Indians/Alaska Native, Hispanic, and white individuals. Asian men had the highest relative increase in ALD-related mortality, likely due to low baseline ALD mortality. Full estimates are available in Supplemental Table 1 .

Based on the Joinpoint analysis, we identified strong statistical evidence for a single change-point in February 2020 for both sexes. Among males, the monthly percent change of crude ALD-related mortality counts was 0.36 (95% CI 0.21 -0.51) prior to February 2020 and 3.18 (95% CI 2.20 -4.17) after February 2020, corresponding to an average monthly percent change from January 2017 through December 2020 of 0.96 (96% CI 0.73 -1.19) ( Figure 1A ).

Among females, the monthly percent change was 0.46 (95% CI 0.28 -0.64) prior to February 2020 and 3.8 (95% CI 2.70 -5.07) after February 2020, corresponding to an average of 1.18 (95% CI 0.90 -1.46) from January 2017 through December 2020 ( Figure 1B) . Hypothesis tests comparing estimated regression slopes before and after the identified change-points were significant (p<0.001 for both sexes). Subgroup analyses suggested significant pre-to-postchange-point monthly percent change differences for most subgroups and particularly among young adults. Among males aged 25-34, the average monthly percent changes in crude mortality were 1.29 (95% CI 0.81 -1.78) and 5.37 (95% CI 3.28 -7.50) before and after February 2020, respectively. Among females aged 25-34, the monthly percent changes were 0.92 (95% CI 0.33 -1.51) and 5.12 (95% CI 1.39 -8.98) before and after February 2020. Similar increases in the average monthly percent changes in crude mortality were seen after February 2020 in all age and J o u r n a l P r e -p r o o f race/ethnicity subgroups with the exception of males >85 years old. Full estimates are available in Supplemental Table 2 .

Using US mortality data from the CDC, we found that mortality from ALD increased in most demographic groups and accelerated during the COVID-19 pandemic. These represent the first population-level data describing trends in mortality from ALD from 2017-2020. Females and younger adults experienced the highest relative increase in ALD-related mortality.

One underlying explanation for these trends is the rise in alcohol consumption and alcohol-related complications prior to and during the pandemic. 7 The pandemic may have also compromised appropriate healthcare for patients with ALD. Other potential contributors include rising obesity/metabolic syndrome and comorbid non-alcoholic fatty liver disease, which can increase risk for the development of ALD. 8 Adults ages 85 years and older had smaller total increases in ALD mortality (females) and even decreases (males) over the study period. This trend likely reflects that mortality from other causes becomes more common in this age group, and that adults with higher-risk alcohol consumption may be less likely to live beyond 84 years.

Although the pandemic likely contributed to this trend, our analysis indicates that some increases in ALD mortality, both in rate and absolute count, were seen prior to the pandemic.

Policies to reduce alcohol consumption could include changes in taxation, which have been successful in reducing alcohol consumption in other countries. 9 Screening for high-risk alcohol use could be improved. Although recommended by the United States Preventive Services Task Force, validated screening tools and referral to evidence-based treatment are underused by primary care physicians. 10 While these national data provide important insight into rising ALD burden, our study has limitations. Estimates of mortality based on death certificates can be inaccurate. Since we J o u r n a l P r e -p r o o f used the Primary Underlying Cause of Death database, this data reflects a conservative estimate of ALD-related mortality. Furthermore, we did not have reliable monthly population denominator estimates, thus precluding the use of rate estimates for change-point analyses.

ALD mortality is increasing among males and females in almost every age and racial/ethnic demographic in the US. These troubling trends call for a nationwide effort to reduce national alcohol consumption, improve alcohol use disorder screening, and optimize early treatment. Other countries have demonstrated success with broad policy change, 9 

Trends in Alcohol-Induced Deaths in the United States

Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US

Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis

Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States

Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century

Permutation tests for joinpoint regression with applications to cancer rates

Effect of Increased Alcohol Consumption During COVID-19 Pandemic on Alcohol-related Liver Disease: A Modeling Study

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities

Impact of minimum unit pricing on alcohol purchases in Scotland and Wales: controlled interrupted time series analyses

Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists

Supplemental Table 2. Monthly change in crude ALD-related mortality counts

AMPC (All)* AMPC (Pre)* AMPC

All" refers to entire study period; "pre" refers to